Application of formononetin

A technology for formononetin and pulmonary fibrosis, which is applied in the directions of medical preparations containing active ingredients, respiratory diseases, organic active ingredients, etc., to achieve good therapeutic effects, easy acceptance, and easy access.

Inactive Publication Date: 2018-11-23
TIANJIN INT JOINT ACADEMY OF BIOTECH & MEDICINE
View PDF2 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

So far, there is no report that for...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of formononetin
  • Application of formononetin
  • Application of formononetin

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0033] The establishment of embodiment 1 mouse pulmonary fibrosis model and pharmacodynamics detection experimental method and steps:

[0034] 1. Establishment of mouse pulmonary fibrosis model

[0035] The 36 mice were randomly divided into three groups, blank control group (normal saline group / normal control group), pulmonary fibrosis model group (bleomycin), and formononetin group (administration of formononetin after modeling anthocyanin), 12 rats in each group.

[0036] Pulmonary fibrosis animal model preparation refers to male C57BL / 6J, (age 8-10 weeks) wild-type mice, with 10% chloral hydrate by intraperitoneal injection of 0.5ml / 100g to give mice anesthesia, intratracheal invasive injection of 2U / Kg bleomycin. The specific implementation method is as follows: after the mouse is anesthetized, weigh and record, fix the mouse on the operating table, disinfect the neck with 70% alcohol, use a scalpel to make a vertical wound of about 1 cm in the neck of the mouse, and u...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides application of formononetin in preparing drug for treating pulmonary fibrosis, which is the novel application of formononetin. According to the invention, the formononetin has good effect for pulmonary fibrosis, has no adverse reaction, can slow down the pulmonary fibrosis of mice induced by the bleomycin and has a good application prospect for treating, slowing down or improving the pulmonary fibrosis.

Description

technical field [0001] The invention relates to the field of medicinal chemistry, in particular to the application of formononetin containing formononetin. Background technique [0002] Organ fibrosis is a pathological change in which fibrous connective tissue increases and parenchymal cells decrease in organ tissues caused by various acute and chronic diseases, and is a common pathological feature of many chronic diseases. Sustained progression of fibrosis can lead to organ structural damage and functional decline, and organ failure caused by fibrosis of parenchymal organs (such as heart, liver, lung, kidney, etc.) is the main cause of disability and death in patients. According to relevant statistical data in the United States, nearly 45% of the patients who died of various diseases in developed countries can be attributed to tissue fibroproliferative diseases. Pulmonary fibrosis is an important component of visceral fibrosis, which is triggered by chronic, recurrent and ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/352A61P11/00
CPCA61K31/352A61P11/00
Inventor 饶子和漆敏杨诚周红刚孙涛李霄鹤高晶晶刘帅帅黄梦莹毛家贺吕紫薇黄凯
Owner TIANJIN INT JOINT ACADEMY OF BIOTECH & MEDICINE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products